Readystate Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,153	Closed	-$336K	–	436
2024 Q3	$336K	Buy	+7,153	New	+$336K	0.01%	259
2024 Q2	–	Sell	-11,773	Closed	-$802K	–	400
2024 Q1	$802K	Buy	+11,773	New	+$802K	0.01%	186